Some 55 U.S. hospitals agreed to pay a total of $34 million to settle U.S. Justice Dept. charges that they overcharged Medicare for Medtronic‘s (NYSE:MDT)’s kyphoplasty spine procedure, acquired in the $3.9 billion buyout of Kyphon in 2007, the Justice Dept. said today.
U.S. Justice Dept. (DOJ)
ArthroCare, Justice Dept. ink 4th extension
For the 4th time in a year, ArthroCare and the Justice Department extended their deadline to strike a deal in an ongoing criminal probe into the company’s spinal business unit.
The Austin, Tex-based company and the DOJ entered into another tolling agreement, a deal that extends statute of limitation rules, until August 31st. The negotiations were 1st extended in January, and the most recent tolling agreement was set to close May 31.
The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
Ex-Arthrocare exec pleads guilty to stock fraud scheme
Ex-ArthroCare (NSDQ:ARTC) executive David Applegate pleaded guilty this week to federal charges that he helped run a scheme that eventually defrauded investors in the medical device company of some $400 million.
U.S. Justice Dept. closes St. Jude Riata probe
Healthcare giant St. Jude Medical (NYSE:STJ) revealed in a recent regulatory filing that U.S. Justice Dept. investigators closed a probe of the recalled Riata and Riata ST defibrillators leads.
CareFusion settles federal marketing probe for $41M
CareFusion (NYSE:CFN) agreed to pay $41 million to settle a 2-year federal probe into the sales and marketing of its ChloraPrep line of antiseptic wipes.
Updated: Justice Dept., ArthroCare get another extension in criminal probe
Updated April 1, 2013, at 2:10 p.m. with stock activity.
ArthroCare (NSDQ:ARTC) and the U.S. Justice Dept. gave themselves until the end of May to hash out a deal over a criminal probe into ArthroCare’s spinal business.
ArthroCare, Justice Dept. extend deal again
ArthroCare (NSDQ:ARTC) and the U.S. Justice Dept. extended by a month the statute of limitations on a federal inquiry from the U.S. Dept. of Justice in to the company’s spinal business.
In January Austin, Texas-based ArthroCare said it was pushing the deal out until March 1. That extension was added to Feb. 27, pushing the deal out to March 30, according to a regulatory filing.
Zimmer: Justice Dept.-SEC probe is over
ArthroCare shares flat on DoJ overhang despite swings to Q4, 2012 black
Investors stayed on the sidelines last week on shares of ArthroCare (NSDQ:ARTC), despite its return to black ink for both the 4th quarter and full year, as they awaited more information on pending U.S. Justice Dept. investigations.
Healthcare fraud recovery pays for itself – and then some | MassDevice.com On Call
MASSDEVICE ON CALL — For every $1 regulators spend fighting healthcare fraud and abuse during the last 3 years they recovered a record $7.90, the highest 3-year average return to date.
Healthcare fraud prevention programs collected $4.2 billion in fiscal year 2012, up from about $4.1 billion in 2011. Over the last 4 years the policing initiatives have recovered $14.9 billion, according to an official report.